VSTM
Verastem Inc
Price:  
5.60 
USD
Volume:  
1,298,088.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Verastem WACC - Weighted Average Cost of Capital

The WACC of Verastem Inc (VSTM) is 16.1%.

The Cost of Equity of Verastem Inc (VSTM) is 8.30%.
The Cost of Debt of Verastem Inc (VSTM) is 103.30%.

Range Selected
Cost of equity 7.20% - 9.40% 8.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 199.60% 103.30%
WACC 6.9% - 25.3% 16.1%
WACC

Verastem WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.81
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 199.60%
After-tax WACC 6.9% 25.3%
Selected WACC 16.1%

Verastem's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Verastem:

cost_of_equity (8.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.72) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.